Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Inventory (2020 - 2025)

Journey Medical (DERM) has disclosed Inventory for 6 consecutive years, with $12.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 2.5% year-over-year to $12.6 million, compared with a TTM value of $12.6 million through Sep 2025, up 2.5%, and an annual FY2024 reading of $14.9 million, up 46.42% over the prior year.
  • Inventory was $12.6 million for Q3 2025 at Journey Medical, down from $13.6 million in the prior quarter.
  • Across five years, Inventory topped out at $16.2 million in Q1 2022 and bottomed at $9.9 million in Q4 2021.
  • Average Inventory over 5 years is $12.9 million, with a median of $13.1 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 602.42% in 2021, then tumbled 30.04% in 2023.
  • Year by year, Inventory stood at $9.9 million in 2021, then surged by 47.92% to $14.6 million in 2022, then crashed by 30.04% to $10.2 million in 2023, then surged by 46.42% to $14.9 million in 2024, then dropped by 15.85% to $12.6 million in 2025.
  • Business Quant data shows Inventory for DERM at $12.6 million in Q3 2025, $13.6 million in Q2 2025, and $13.3 million in Q1 2025.